Cardiovascular-kidney-metabolic syndrome: novel molecular mechanism and glucagon-like peptide-1-targeting therapy.
This newly indexed research record examines “Cardiovascular-kidney-metabolic syndrome: novel molecular mechanism and glucagon-like peptide-1-targeting therapy.” Use the linked PubMed (NCBI) publication to assess the study design, population, methods, findings and limitations; an indexed record alone should not be read as clinical guidance.
Open original source ↗Collected Nov 8, 2026. Third-party data may change. Consult the original publication or registry for complete methods, findings and status.